Eric Lorraine, DO
Family Medicine · Endwell, NYNPI 1801114285
Payments from drug & device makers
Across 363 payments — averaging $2037.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$221K
- GSK$187K
- Eli Lilly$120K
- Currax Pharmaceuticals LLC$97K
- AstraZeneca$43K
- Sanofi Pasteur Inc.$36K
- plus $34K from 27 others
Across 26 payments — averaging $204.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$3K
- GSK$2K
- Eli Lilly$680
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 10 | $221,288 |
| GSK | 65 | $187,474 |
| Eli Lilly | 14 | $119,996 |
| Currax Pharmaceuticals LLC | 23 | $97,292 |
| AstraZeneca | 15 | $43,423 |
| Sanofi Pasteur Inc. | 3 | $36,330 |
| Esperion Therapeutics, Inc. | 46 | $29,024 |
| Novo Nordisk | 35 | $2,275 |
| AbbVie(2 entities) | 56 | $1,195 |
| Lilly USA, LLC | 17 | $285 |
| Pfizer | 36 | $274 |
| Stryker | 1 | $139 |
| Boehringer Ingelheim | 6 | $100 |
| Phathom Pharmaceuticals, Inc. | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $59 |
| Abbott | 3 | $47 |
| Edwards Lifesciences | 1 | $46 |
| Irhythm Technologies, Inc. | 1 | $38 |
| Corium, LLC | 3 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Corcept Therapeutics | 2 | $30 |
| Exact Sciences | 2 | $29 |
| Novartis | 2 | $26 |
| Johnson & Johnson | 2 | $26 |
| Verona Pharma, Inc. | 1 | $24 |
| Merck | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Gilead | 1 | $14 |
| Si-bone, Inc. | 2 | $14 |
| Bayer | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Neuronetics, Inc. | 1 | $10 |
How this compares
$739,675 in reported general payments places this provider in the 95th percentile of 4,321 family medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Endwell
- Suchet PatelEndwell$23.3M
- Michael FedericoEndwell$1.4M
- Kimberly DesantisEndwell$1.1M
- Bruce BowlingEndwell$287K
- Duncan Sze-TuEndwell$227K
- Rekha PatelEndwell$161K
- Matthew DavisRochester$76.6M
- Frank EderBinghamton$46.2M
- James WildGowanda$2.2M
- Donald BrautigamWestfield$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.